New Jersey Assembly Bill AJR227

New Jersey 2022-2023 Regular Session

• Introduced: 5/18/23
• Refer: 5/18/23

Caption

Designates last day of February of each year as "Rare Disease Awareness Day" in New Jersey.

Impact

By officially recognizing Rare Disease Awareness Day, AJR227 seeks to highlight the significant challenges faced by individuals suffering from rare diseases, which often include obtaining timely and accurate diagnoses and accessing effective treatment options. The resolution aims to facilitate the sharing of crucial information and foster improved policies that support medical research and the development of treatment options for these conditions. Furthermore, it aims to alleviate the sense of isolation that many patients and families experience.

Summary

AJR227 is a joint resolution introduced in the New Jersey legislature aiming to designate the last day of February each year as 'Rare Disease Awareness Day.' The purpose of this resolution is to raise public awareness of rare diseases, encourage support for patients and families affected by these conditions, and promote further research into their treatment. Rare diseases are defined by the National Institutes of Health as conditions affecting fewer than 200,000 people, with nearly 30 million Americans impacted by close to 7,000 distinct rare disorders.

Statement

The resolution encourages the Governor to annually issue a proclamation observing Rare Disease Awareness Day, calling for public officials and citizens of New Jersey to engage in appropriate activities and programs that raise awareness. The passing of AJR227 can mark an important cultural shift, empowering affected communities and influencing future health policy towards a more comprehensive approach to healthcare for rare disease patients.

Contention

While the resolution primarily serves a supportive and educational purpose, there could be discussions about the effectiveness of such proclamations in translating awareness into action at the legislative level, including funding for research and patient support services. There may also be differing opinions on the prioritization of rare diseases versus other pressing public health issues, particularly in the context of limited state resources.